+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Oncology NGS Market Research Report by Technology (Amplicon-based, Hybridization-based, and Targeted & Gene Panel Sequencing), Product & Service, Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 251 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5715540
UP TO OFF until Mar 31st 2023
The Global Oncology NGS Market size was estimated at USD 381.23 million in 2022, USD 438.26 million in 2023, and is projected to grow at a CAGR of 15.41% to reach USD 1,200.39 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Oncology NGS Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Oncology NGS Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Oncology NGS Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Oncology NGS Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Oncology NGS Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market is studied across Amplicon-based, Hybridization-based, Targeted & Gene Panel Sequencing, Whole Exome Sequencing, and Whole Genome Sequencing.
  • Based on Product & Service, the market is studied across Platforms & Related Products and Services. The Platforms & Related Products is is further studied across Consumables, Panels, and Platforms. The Services is is further studied across By Workflow, NGS Data Analysis, NGS Pre-Sequencing, NGS Primary Data Analysis, NGS Secondary Data Analysis, NGS Sequencing, and NGS Tertiary Data Analysis.
  • Based on Application, the market is studied across Academic & Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Oncology NGS Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Oncology NGS Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Oncology NGS Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Oncology NGS Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Oncology NGS Market, including 4basecare Onco Solutions Private Limited, BGI Group, Caris Life Sciences, Eurofins Scientific SE, Foundation Medicine, Inc., Genotypic Technology Pvt. Ltd., Hologic, Inc., MedGenome, Myriad Genetics, Inc., PerkinElmer Inc., Premas Life Sciences, Sayre Therapeutics Pvt Ltd., SciGenom Labs Pvt. Ltd., Tecan Trading AG, Vela Diagnostics Holding Pte Ltd., and Xcelris Labs Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Oncology NGS Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oncology NGS Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oncology NGS Market?
4. What is the competitive strategic window for opportunities in the Global Oncology NGS Market?
5. What are the technology trends and regulatory frameworks in the Global Oncology NGS Market?
6. What is the market share of the leading vendors in the Global Oncology NGS Market?
7. What modes and strategic moves are considered suitable for entering the Global Oncology NGS Market?
Frequently Asked Questions about the Global Oncology NGS Market

What is the estimated value of the Global Oncology NGS Market?

The Global Oncology NGS Market was estimated to be valued at $381.23 Million in 2022.

What is the growth rate of the Global Oncology NGS Market?

The growth rate of the Global Oncology NGS Market is 15.4%, with an estimated value of $1200.39 Million by 2030.

What is the forecasted size of the Global Oncology NGS Market?

The Global Oncology NGS Market is estimated to be worth $1200.39 Million by 2030.

Who are the key companies in the Global Oncology NGS Market?

Key companies in the Global Oncology NGS Market include 4basecare Onco Solutions Private Limited, BGI Group, Caris Life Sciences, Eurofins Scientific SE, Foundation Medicine, Inc., Genotypic Technology Pvt. Ltd., Hologic, Inc., MedGenome and PerkinElmer Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential demand attributed to rising prevalence of cancer incidence globally
5.1.1.2. Growing popularity of personalized medicine in clinical oncology
5.1.1.3. Increasing consumer adoption owing to decreasing costs for genetic sequencing solutions
5.1.2. Restraints
5.1.2.1. Lack of computational efficiency for data management
5.1.3. Opportunities
5.1.3.1. Rising governmental initiatives and investments in the field of research and development in oncology
5.1.3.2. Emerging advancements for whole-genome sequencing worldwide
5.1.4. Challenges
5.1.4.1. Limited and inadequate reimbursement policies
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Oncology NGS Market, by Technology
6.1. Introduction
6.2. Amplicon-based
6.3. Hybridization-based
6.4. Targeted & Gene Panel Sequencing
6.5. Whole Exome Sequencing
6.6. Whole Genome Sequencing

7. Oncology NGS Market, by Product & Service
7.1. Introduction
7.2. Platforms & Related Products
7.3.1. Consumables
7.3.2. Panels
7.3.3. Platforms
7.3. Services
7.4.1. By Workflow
7.4.2. NGS Data Analysis
7.4.3. NGS Pre-Sequencing
7.4.4. NGS Primary Data Analysis
7.4.5. NGS Secondary Data Analysis
7.4.6. NGS Sequencing
7.4.7. NGS Tertiary Data Analysis

8. Oncology NGS Market, by Application
8.1. Introduction
8.2. Academic & Clinical Research
8.3. Hospitals & Clinics
8.4. Pharma & Biotech Entities

9. Americas Oncology NGS Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Oncology NGS Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Oncology NGS Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 4basecare Onco Solutions Private Limited
13.2. BGI Group
13.3. Caris Life Sciences
13.4. Eurofins Scientific SE
13.5. Foundation Medicine, Inc.
13.6. Genotypic Technology Pvt. Ltd.
13.7. Hologic, Inc.
13.8. MedGenome
13.9. Myriad Genetics, Inc.
13.10. PerkinElmer Inc.
13.11. Premas Life Sciences
13.12. Sayre Therapeutics Pvt Ltd.
13.13. SciGenom Labs Pvt. Ltd.
13.14. Tecan Trading AG
13.15. Vela Diagnostics Holding Pte Ltd.
13.16. Xcelris Labs Ltd.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL ONCOLOGY NGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ONCOLOGY NGS MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ONCOLOGY NGS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ONCOLOGY NGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL ONCOLOGY NGS MARKET DYNAMICS
FIGURE 11. GLOBAL ONCOLOGY NGS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 13. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ONCOLOGY NGS MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 15. GLOBAL ONCOLOGY NGS MARKET SIZE, BY AMPLICON-BASED, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGETED & GENE PANEL SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 19. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 20. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
FIGURE 21. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 22. GLOBAL ONCOLOGY NGS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT & SERVICE, 2030
FIGURE 23. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
FIGURE 25. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PANELS, 2018-2030 (USD MILLION)
FIGURE 26. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BY WORKFLOW, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS DATA ANALYSIS, 2018-2030 (USD MILLION)
FIGURE 30. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRE-SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 31. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRIMARY DATA ANALYSIS, 2018-2030 (USD MILLION)
FIGURE 32. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SECONDARY DATA ANALYSIS, 2018-2030 (USD MILLION)
FIGURE 33. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SEQUENCING, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS TERTIARY DATA ANALYSIS, 2018-2030 (USD MILLION)
FIGURE 35. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 36. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 37. GLOBAL ONCOLOGY NGS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 38. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & CLINICAL RESEARCH, 2018-2030 (USD MILLION)
FIGURE 39. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
FIGURE 40. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, 2018-2030 (USD MILLION)
FIGURE 41. AMERICAS ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 43. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 44. AMERICAS ONCOLOGY NGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 45. ARGENTINA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. BRAZIL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. CANADA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. MEXICO ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. UNITED STATES ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 51. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 52. UNITED STATES ONCOLOGY NGS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 53. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 55. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 56. ASIA-PACIFIC ONCOLOGY NGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 57. AUSTRALIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. CHINA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. INDIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. INDONESIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. JAPAN ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. MALAYSIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. PHILIPPINES ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. SINGAPORE ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. TAIWAN ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. THAILAND ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. VIETNAM ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 73. DENMARK ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. EGYPT ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. FINLAND ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. FRANCE ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. GERMANY ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. ISRAEL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. ITALY ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. NETHERLANDS ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. NIGERIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. NORWAY ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. POLAND ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. QATAR ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. RUSSIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. SPAIN ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. SWEDEN ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. SWITZERLAND ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 91. TURKEY ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 92. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 93. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 94. GLOBAL ONCOLOGY NGS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 95. GLOBAL ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 96. GLOBAL ONCOLOGY NGS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL ONCOLOGY NGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY AMPLICON-BASED, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY AMPLICON-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY AMPLICON-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HYBRIDIZATION-BASED, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HYBRIDIZATION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HYBRIDIZATION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGETED & GENE PANEL SEQUENCING, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGETED & GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ONCOLOGY NGS MARKET SIZE, BY TARGETED & GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS & RELATED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PANELS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BY WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BY WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRE-SEQUENCING, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRIMARY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRIMARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS PRIMARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SECONDARY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SECONDARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SECONDARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SEQUENCING, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS TERTIARY DATA ANALYSIS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS TERTIARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ONCOLOGY NGS MARKET SIZE, BY NGS TERTIARY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC & CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. CANADA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 83. CANADA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. CANADA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 85. CANADA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. MEXICO ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. MEXICO ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. CHINA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 105. CHINA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. CHINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 107. CHINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. INDIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 109. INDIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. INDIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 111. INDIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. JAPAN ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 117. JAPAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. JAPAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 119. JAPAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. PHILIPPINES ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 125. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 131. SINGAPORE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. THAILAND ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 141. THAILAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. THAILAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 143. THAILAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. DENMARK ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. EGYPT ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 158. EGYPT ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. EGYPT ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 160. EGYPT ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. FINLAND ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 162. FINLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. FINLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 164. FINLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. FRANCE ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 166. FRANCE ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. FRANCE ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 168. FRANCE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. GERMANY ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 170. GERMANY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. GERMANY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 172. GERMANY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. ISRAEL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 174. ISRAEL ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. ITALY ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 178. ITALY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. ITALY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 180. ITALY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. NORWAY ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 190. NORWAY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. NORWAY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 192. NORWAY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. POLAND ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 194. POLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. POLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 196. POLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. QATAR ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 198. QATAR ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. QATAR ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 200. QATAR ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SPAIN ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 214. SPAIN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. SPAIN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 216. SPAIN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. GLOBAL ONCOLOGY NGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 238. GLOBAL ONCOLOGY NGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 239. GLOBAL ONCOLOGY NGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 240. GLOBAL ONCOLOGY NGS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 241. GLOBAL ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 242. GLOBAL ONCOLOGY NGS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 243. GLOBAL ONCOLOGY NGS MARKET MERGER & ACQUISITION
TABLE 244. GLOBAL ONCOLOGY NGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 245. GLOBAL ONCOLOGY NGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 246. GLOBAL ONCOLOGY NGS MARKET INVESTMENT & FUNDING
TABLE 247. GLOBAL ONCOLOGY NGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 248. GLOBAL ONCOLOGY NGS MARKET: LICENSE & PRICING

Companies Mentioned

  • 4basecare Onco Solutions Private Limited
  • BGI Group
  • Caris Life Sciences
  • Eurofins Scientific SE
  • Foundation Medicine, Inc.
  • Genotypic Technology Pvt. Ltd.
  • Hologic, Inc.
  • MedGenome
  • Myriad Genetics, Inc.
  • PerkinElmer Inc.
  • Premas Life Sciences
  • Sayre Therapeutics Pvt Ltd.
  • SciGenom Labs Pvt. Ltd.
  • Tecan Trading AG
  • Vela Diagnostics Holding Pte Ltd.
  • Xcelris Labs Ltd.

Methodology

Loading
LOADING...